RE: How to value GDR19 Jun 2020 10:34
Its tricky. I personally take both rampers and derampers with a pinch of salt.
Naturally those heavily invested believe their forecasts, it is in their interest to do so. I'm included in that bracket.
From these lows there is a high chance of a strong upside. Mcap is at sub 60m, if the product is as good as I believe, compared to the competition - we are partnered with Cytivia (GE), I'd expect us to generate revenues equal to our existing Mcap before the closing of 2020, and that is on my low estimate. So naturally if successful we will rerate massively.
But I'd suggest doing your own research for sure, as equally you may identify a red flag that doesnt suit your risk appetite.